Mathematical simulations of the effects of altered AMP-kinase activity on INa and the action potential in rat ventricle

Journal of Cardiovascular Electrophysiology

Volumn 17, Issue SUPPL. 1, 2006, Pages

  Bazzazi, H ^a   Clark, R B ^a   Giles, W R ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMP kinase; Arrhythmia; Mathematical simulations; Na+ current

Indexed keywords

ADENYLATE KINASE; CALCIUM CHANNEL L TYPE; CALCIUM ION; SODIUM CHANNEL; SODIUM ION;

ANIMAL CELL; ARRHYTHMOGENESIS; CALCIUM CURRENT; CONFERENCE PAPER; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART VENTRICLE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT;

ACTION POTENTIALS; ADAPTATION, PHYSIOLOGICAL; ADENYLATE KINASE; ANIMALS; ARRHYTHMIA; CELL MEMBRANE; COMPUTER SIMULATION; ENZYME ACTIVATION; HEART VENTRICLES; ION CHANNEL GATING; MEMBRANE POTENTIALS; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; RATS; SODIUM; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646003279     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00402.x     Document Type: Conference Paper

References (42)

1. Ruderman NB Park H Kaushik VK Dean D Constant S Prentki M Saha AK AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise. Acta Physiol Scand 2003 178 435 442.
2. Sambandam N Lopaschuk GD AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 2003 42 238 256.
3. Hopkins TA Dyck JR Lopaschuk GD AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart. Biochem Soc Trans 2003 31 207 212.
4. Park SH Paulsen SR Gammon SR Mustard KJ Hardie DG Winder WW Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle. J Appl Physiol 2002 93 2081 2088.
5. Gibbs CL Cardiac energetics: Sense and nonsense. Clin Exp Pharmacol Physiol 2003 30 598 603.
6. + exchange blockers. J Mol Cell Cardiol 2000 32 1181 1192.
7. Gollob MH Seger JJ Gollob TN Tapscott T Gonzales O Bachinski L Roberts R Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001 104 3030 3033.
8. Gollob MH Green MS Tang AS Roberts R PRKAG2 cardiac syndrome: Familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr Opin Cardiol 2002 17 229 234.
9. Gollob MH Roberts R AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: New perspectives on heart development and arrhythmogenesis. Eur Heart J 2002 23 679 681.
10. Sidhu JS Rajawat YS Rami TG Gollob MH Wang Z Yuan R Marian AJ DeMayo FJ Weilbacher D Taffet GE Davies JK Carling D Khoury DS Roberts R Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 2005 111 21 29.
11. Arad M Benson DW Perez-Atayde AR McKenna WJ Sparks EA Kanter RJ McGarry K Seidman JG Seidman CE Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002 109 357 362.
12. 2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001 10 1215 1220.
13. Oliveira SM Ehtisham J Redwood CS Ostman-Smith I Blair EM Watkins H Mutation analysis of AMP-activated protein kinase subunits in inherited cardiomyopathies: Implications for kinase function and disease pathogenesis. J Mol Cell Cardiol 2003 35 1251 1255.
14. Light PE Wallace CH Dyck JR Constitutively active adenosine monophosphate-activated protein kinase regulates voltage-gated sodium channels in ventricular myocytes. Circulation 2003 107 1962 1965.
15. Pandit SV Clark RB Giles WR Demir SS A mathematical model of action potential heterogeneity in adult rat left ventricular myocytes. Biophys J 2001 81 3029 3051.
16. Shiferaw Y Watanabe MA Garfinkel A Weiss JN Karma A Model of intracellular calcium cycling in ventricular myocytes. Biophys J 2003 85 3666 3686.
17. Clancy CE Rudy Y Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 1999 400 566 569.
18. Goldman L Balke CW Do defects in the late sodium current in human ventricular cells cause heart failure? J Mol Cell Cardiol 2002 34 1473 1476.
19. + channel in normal and failing human myocardium. J Mol Cell Cardiol 2002 34 1477 1489.
20. Valdivia CR Chu WW Pu J Foell JD Haworth RA Wolff MR Kamp TJ Makielski JC Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005 38 475 483.
21. Maltsev VA Sabbah HN Undrovinas AI Late sodium current is a novel target for amiodarone: Studies in failing human myocardium. J Mol Cell Cardiol 2001 33 923 932.
22. + regulation in cardiac myocytes. Cardiovasc Res 2003 57 897 912.
23. i overloaded cardiac myocytes: A simulation study. Biophys J 2000 78 2392 2404.
24. +] in a human atrial strand. Ann Biomed Eng 2000 28 951 957.
25. Sampson KJ Henriquez CS Electrotonic influences on action potential duration dispersion in small hearts: A simulation study. Am J Physiol 2005 289 SH350 H360.
26. Clancy CE Tateyama M Kass RS Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. J Clin Invest 2002 110 1251 1262.
27. Ward CA Giles WR Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 1997 500 631 642.
28. Na in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 2004 44 192 199.
29. 1-subunits. Circ Res 1998 83 141 146.
30. Maier SK Westenbroek RE McCormick KA Curtis R Scheuer T Catterall WA Distinct subcellular localization of different sodium channel α and β subunits in single ventricular myocytes from mouse heart. Circulation 2004 109 1421 1427.
31. Jafri MS Dudycha SJ O'Rourke B Cardiac energy metabolism: Models of cellular respiration. Ann Rev Biomed Eng 2001 3 57 81.
32. Goryanin I Hodgman TC Selkov E Mathematical simulation and analysis of cellular metabolism and regulation. Bioinformatics 1999 15 749 758.
33. Ingwall JS Transgenesis and cardiac energetics: New insights into cardiac metabolism. J Mol Cell Cardiol 2004 37 613 623.
34. Matsuoka S Sarai N Jo H Noma A Simulation of ATP metabolism in cardiac excitation-contraction coupling. Prog Biophys Mol Biol 2004 85 279 299.
35. 87Rb NMR spectroscopic study. Magn Reson Med 1995 34 673 685.
36. Saucerman JJ Brunton LL Michailova AP McCulloch AD Modeling β-adrenergic control of cardiac myocyte contractility in silico. J Biol Chem 2003 278 47997 48003.
37. Saucerman JJ McCulloch AD Mechanistic systems models of cell signaling networks: A case study of myocyte adrenergic regulation. Prog Biophys Mol Biol 2004 85 261 278.
38. Saucerman JJ Healy SN Belik ME Puglisi JL McCulloch AD Proarrhythmic consequences of a KCNQ1 AKAP-binding domain mutation: Computational models of whole cells and heterogeneous tissue. Circ Res 2004 95 1216 1224.
39. Yarbrough TL Lu T Lee HC Shibata EF Localization of cardiac sodium channels in caveolin-rich membrane domains: Regulation of sodium current amplitude. Circ Res 2002 90 443 449.
40. Kambouris NG Nuss HB Johns DC Marban E Tomaselli GF Balser JR A revised view of cardiac sodium channel "blockade" in the long-QT syndrome. J Clin Invest 2000 105 1133 1140.
41. Glaaser IW Kass RS Clancy CE Mechanisms of genetic arrhythmias: from DNA to ECG. Prog Cardiovasc Dis 2003 46 259 270.
42. Schwartz PJ Priori SG Spazzolini C Moss AJ Vincent GM Napolitano C Denjoy I Guicheney P Breithardt G Keating MT Towbin JA Beggs AH Brink P Wilde AA Toivonen L Zareba W Robinson JL Timothy KW Corfield V Wattanasirichaigoon D Corbett C Haverkamp W Schulze-Bahr E Lehmann MH Schwartz K Coumel P Bloise R Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001 103 89 95.